Navigation Links
Savient Pharmaceuticals Reports Second Quarter 2009 Financial Results
Date:8/10/2009

suance of the warrants and the end of the quarter, the fair value of the warrants also increased, and we were required to record a non-cash charge of $35.8 million due to the valuation adjustment, in other expense, net, within our consolidated statements of operations.

The net loss for the first six months of 2009 was $76.8 million or $1.35 per basic and diluted share on total revenues of $1.8 million, compared with a net loss of $41.8 million or $0.78 per basic and diluted share on total revenues of $1.5 million for the same period in 2008. On a non-GAAP basis, excluding the $35.8 million non-cash charge due to the valuation adjustment on our warrants, our net loss for the first six months of 2009 was $41.0 million, or $0.72 per basic and diluted share, compared with a GAAP net loss of $41.8 million for the second quarter of 2008, or $0.78 per basic and diluted share.

"Given the delay in a potential approval of our Biologics License Application (BLA) for KRYSTEXXA(TM) (pegloticase), our biologic PEGylated uricase enzyme, we have begun implementing immediate measures to further conserve cash and reduce our cash burn, while we concentrate our efforts to remedy the chemistry, manufacturing and controls (CMC) issues identified in the complete response letter received from the Food and Drug Administration (FDA) on July 31, 2009," said Paul Hamelin, President of Savient. "We will suspend many of our pre-launch commercialization activities and are able to do so without jeopardizing our launch readiness in light of the significant interactions we have already engaged in with the FDA on our package insert which has enabled us to bring to near conclusion many of our pre-launch commercialization activities. Until we regain greater certainty regarding the timing of a potential approval of KRYSTEXXA, our spend on commercialization activities will be reduced to the minimum needed to generally maintain our current state of launch readines
'/>"/>

SOURCE Savient Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related medicine news :

1. Savient Pharmaceuticals to Present at the Credit Suisse Phoenix Healthcare Conference on November 13th
2. Savients Board of Directors Forms a Board Committee to Oversee the Regulatory and Pre-Launch Activities for Pegloticase
3. Savient Pharmaceuticals to Present at the 27th Annual J.P. Morgan Healthcare Conference on January 14th
4. Savient Pharmaceuticals Reports Fourth Quarter and Year-End 2008 Financial Results
5. Savient Pharmaceuticals to Present at The Cowen and Company 29th Annual Healthcare Conference on March 17, 2009
6. Savient Pharmaceuticals Receives Complete Response Letter from U.S. Food and Drug Administration for KRYSTEXXA(TM)
7. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
8. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
9. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
10. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
11. Vista Partners Updates Coverage on Tapestry Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)... Launch Corporation, LLC. is pleased to announce that ... at 17 Tanguay Avenue. Owned and operated by Rick Arnold ... location in New England. , “We are extremely excited for ... founder, co-owner and CEO of Launch. “They have established great ... seeing them continue to establish that positive growth in the ...
(Date:5/6/2015)... NC (PRWEB) May 06, 2015 LINET ... Award of Charlotte in the small business category. The ... The Mayor’s International Community Award is given on an ... area that exhibit outstanding contributions to philanthropy. Since ... the Mayor have hosted the Mayor’s International Community Awards. ...
(Date:5/6/2015)... May 06, 2015 “ Radiation Island ” ... which takes a look at the latest and coolest applications ... the host of AppWatch and technology expert, conducted the app ... the best graphic games on iOS. , Touted as one ... exceptional. It’s loved by users, which is obvious because of ...
(Date:5/5/2015)... (PRWEB) May 05, 2015 With ProPoint: Hand ... within Final Cut Pro X . With ProPoint: ... 3D space to further more customize each preset all with ... are given up to 90 fully customizable effect presets all ... circles, curved arrows, straight arrows, underlines, and more. , ...
(Date:5/5/2015)... May 06, 2015 The ... original research “ Priority interventions to improve the ... a participatory research of the ACCORD program ” ... “Primary care actors, including clinicians, patients and family ... pain management which included knowledge gap, “work in ...
Breaking Medicine News(10 mins):Health News:Jump Up and Celebrate: Launch Trampoline Park Opens in Nashua, NH 2Health News:LINET Americas Wins The Mayor's International Community Award in Charlotte 2Health News:Top Grossing iPhone Game, Radiation Island, Was Featured on NewsWatch 2Health News:FCPX Plugin Developer Pixel Film Studios release Propoint Hand Drawn 2Health News:Priority interventions in chronic non-cancer pain published by Dove Medical Press 2
... could lead to new diabetes treatments, researchers say , MONDAY, ... involved in both insulin action and insulin resistance has been ... an enzyme called PI 3-kinase plays an important role in ... In tests on cells and genetically modified mice, Joslin Diabetes ...
... ... are to offer Allergan implants as part of their standard breast augmentation package. ... (PRWEB) March 29, 2010 -- ... their ongoing attempt to provide the most comprehensive service to their patients having breast ...
... at the University of Gothenburg, Sweden, has shown in a ... the treatment of lung cancer. The discovery was made when ... transgenic mice. This resulted in inhibition of cell growth, fewer ... is being published in the journal Proceedings of the ...
... March 29, 2010 Elsevier, a world leader in ... announced that its Journal of Evidence-Based Dental Practice ... a special March 2010 issue on restorative dentistry to ... in the U.S. "As the most authoritative ...
... ... of HealthcareSource®, a pioneer in talent management solutions designed for the healthcare industry. ... ... solution provider that offers employment screening and onboarding solutions designed for human resources, ...
... levels can lead to serious health problems, experts say , ... a common health problem around the world, experts say, and ... among poor black and Hispanic children, researchers report. , In ... optimal vitamin D levels, the study found. , "This is ...
Cached Medicine News:Health News:'Jekyll and Hyde' Factor May Control Insulin Function 2Health News:Rubicon Medical To Offer Allergan Implants In Breast Enlargement Surgery 2Health News:Promising strategy for treatment of lung cancer 2Health News:Elsevier's Journal of Evidence-Based Dental Practice celebrates 10th year with special issue 2Health News:TalentWise Integrates Employment Screening with Leading Applicant Tracking Solution for Healthcare Industry TalentWise becomes HealthcareSource Certified Integration Partner For Position Manager Product 2Health News:TalentWise Integrates Employment Screening with Leading Applicant Tracking Solution for Healthcare Industry TalentWise becomes HealthcareSource Certified Integration Partner For Position Manager Product 3Health News:Minority Kids Lack Enough Vitamin D 2Health News:Minority Kids Lack Enough Vitamin D 3
(Date:5/5/2015)... , May 5, 2015  In line with CBME ... to the community with a charity program to create ... autism. CBME China team is coordinating ... and maternity manufacturers, brand owners and distributors. All donated ... July 2015. Proceeds from the sale will be used ...
(Date:5/5/2015)... , May 5, 2015   Temptime Corporation , ... health care industry, announced today that its board of ... to chief executive officer.  Mr. Van den ... since 2011. "Renaat deeply values Temptime,s mission ... job of expanding Temptime,s products and services to organizations ...
(Date:5/5/2015)... Sysmex America, Inc., a global leader ... technology, today announces a partnership with Medicus Middleware, ... Sysmex and its distributor partners to offer a ... and clinics that connect Sysmex,s XP-300 moderately complex ... systems. Physician office-based laboratories (POL) often ...
Breaking Medicine Technology:CBME China Launches Charity Program to Support Children with Autism 2Temptime President Renaat Van den Hooff Promoted to CEO 2Sysmex America, Inc. Partners with Medicus Middleware to Provide Physician Office Labs with Instrument Connectivity Directly to EMR 2Sysmex America, Inc. Partners with Medicus Middleware to Provide Physician Office Labs with Instrument Connectivity Directly to EMR 3
... and Company (NYSE: LLY ) announced results ... genetic mutations and disable specific signaling pathways that can ... – a JAK2 inhibitor and a Hedgehog inhibitor – ... Research (AACR) 102nd Annual Meeting in Orlando, Fla.   ...
... N.C., April 4, 2011 Cardioxyl Pharmaceuticals, Inc. ... from studies of its lead clinical candidate, CXL-1020, ... Annual Scientific Session & Expo in New Orleans, ... demonstrate CXL-1020,s ability to work independently from other ...
Cached Medicine Technology:Two Novel Lilly Molecules Target Genetic Mutations That Can Lead to Cancer 2Two Novel Lilly Molecules Target Genetic Mutations That Can Lead to Cancer 3Two Novel Lilly Molecules Target Genetic Mutations That Can Lead to Cancer 4Cardioxyl Pharmaceuticals Presents Data On Its Clinical Candidate, CXL-1020, at the 60th Annual American College of Cardiology Scientific Session 2Cardioxyl Pharmaceuticals Presents Data On Its Clinical Candidate, CXL-1020, at the 60th Annual American College of Cardiology Scientific Session 3Cardioxyl Pharmaceuticals Presents Data On Its Clinical Candidate, CXL-1020, at the 60th Annual American College of Cardiology Scientific Session 4Cardioxyl Pharmaceuticals Presents Data On Its Clinical Candidate, CXL-1020, at the 60th Annual American College of Cardiology Scientific Session 5
... Bird and Cronin, Inc. ... of Patient Footwear, Orthopedic ... Care Products. Our products ... quality and available in ...
... Bird and Cronin, Inc. ... of Patient Footwear, Orthopedic ... Care Products. Our products ... quality and available in ...
... braces provide pain relief, stabilization and comfort ... patient outcomes. ,The Aspen® "Low Profile" LSO ... When firmly tightened, using the LeverLatch mechanism, ... significant degree of functional mobility and, in ...
... Gunslinger™ Shoulder Orthosis Until now, laborious custom ... of splint. Adjustability was limited and modifications ... best, difficult and cumbersome.,The GunSlinger evolved from ... a major Boston teaching hospital. This orthosis ...
Medicine Products: